DirectorDealingsBot

Oruka Therapeutics insider buys: Joana Gonçalves buys shares at $6.84‑$7.80, signaling confidence in the company’s heart‑failure pipeline and potential upside.

CEO Yuan Eric S. buys 12,100 Zoom shares while the company sells 130,000 shares under a Rule 144 notice—an insider confidence signal and liquidity boost in a resilient software firm.

Alan Baratz’s July 14 sale of 52,320 D‑Wave shares signals routine portfolio rebalancing amid market softness—watch Nasdaq shift, earnings, and insider trends for hints of a rebound.

Insightful insider activity: Meyers sells Nuvalent shares for $124 during GSK merger, revealing premium strategy and post‑merger dynamics.

Beyond Meat insider selling spikes: CFO Lubi’s recent 1,209‑share sale at $0.62 hints at liquidity focus amid market volatility – what it means for investors.

MediaAlpha insider sales in mid‑July reveal tax‑driven liquidity, not distress, amid rising nickel‑cobalt project prospects.

Insider selling at BETA Technologies shows plan‑driven liquidity moves amid volatile sentiment; investors should watch earnings and strategic shifts for growth signals.

Structure Therapeutics insider buying by CSO Lin Xichen signals confident, long‑term value amid a disciplined sell‑off strategy—ideal for savvy biotech investors.

PagerDuty insider moves: executives stack RSUs and buy shares, while leadership refreshes aim to boost AI event‑intelligence and EMEA growth, hinting at a potential rebound.

Insider buying surge signals confidence amid volatility—discover why executives are buying shares, what it means for investors, and the risks to watch.